About this role
Position Description Summary The Director, US Business Analytics serves as a strategic analytics advisor to the US Marketing Leadership Team, influencing portfolio, investment, and growth decisions through data-driven recommendations. Accountable for defining analytics priorities and operating plans across the HAE and Immunoglobulin portfolio to support commercial strategy and business performance objectives. Lead and develop innovative business analytics tools to analyze and advise on complex business problems and issues across CSL (Behring & Vifor) with a focus on the HAE and Ig US portfolio of products contributing more than $5B in annual revenue.
Operate as a business partner to US VP Marketing and the US Marketing leadership team by leading and owning the provision of analysis to provide quantitative market, competitor and brand insights. Manage team responsible for all business analytics in support of CSL inline portfolio products with a focus on the HAE and Ig and late-stage pre-launch development products. Drive innovation in business analytics deployment, data science and actionable insights.
Contribute to portfolio and brand strategy development through metrics, KPI dashboards and performance indicators. Apply strong business acumen to synthesize quantitative and qualitative information into actionable recommendations. Main Responsibilities & Accountabilities Recommend analytics strategies, operating plans, and performance measurement frameworks that directly impact portfolio performance and achievement of commercial objectives.
Lead team of US commercial business analytics professionals to develop, plan and execute commercial data modeling and scenario analysis Lead continuous improvement efforts across analytics approaches, data identification, and team capability development. Decision support utilizing quantitative techniques to analyze market dynamics and present insights to senior leadership, translating complex data into strategic recommendations that influence portfolio priorities and commercial decisions. Direct work through managed resources and offshore delivery centers, ensuring prioritization and efficient delivery of large, complex cross-functional initiatives supporting business and portfolio objectives.
Qualifications & Experience Requirements Bachelor's degree in a quantitative or business field. MBA or other postgraduate qualification preferred. Minimum 12 years relevant Healthcare or Pharma Consulting experience supported by ability to influence stakeholders and senior leadership in developing data driven brand strategies & tactical executions plans.
Strong interpersonal skills to build rapport and credibility with CSL leaders from TA aligned commercial and marketing leaders to Commercial leadership. Knowledge of relevant US business, legal, compliance and regulatory requirements. Experience leading and managing teams in a complex and fast paced environment; global, matrixed, cross-functional experience preferred.
Experience in specialty/rare disease data across multiple data sources strongly preferred. Knowledge of the US plasma ecosystem strongly preferred, including multi-product TA portfolio management, complex contracting approaches and understanding and communicating the business implications of those aspects across the company’s regions to stakeholders to support their decision-making. Advanced knowledge in Pharma commercial data (IQVIA, Komodo, Symphony etc., ) supported by proven analytical skills using Microsoft Office Suite; BI tools such as Power BI and Tableau preferred; SAP/Model N knowledge strongly preferred.
Different qualifications or responsibilities may apply based on local legal and/or educational requirements. Refer to local job documentation where applicable. About CSL Behring CSL Behring is a global biotherapeutics leader driven by our promise to save lives.
Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives. CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma.
Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries. To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/ . Our Benefits For more information on CSL benefits visit How CSL Supports Your Well-being | CSL .
You Belong at CSL At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future.
To learn more about inclusion and belonging visit https://www.csl.com/careers/inclusion-and-belonging Equal Opportunity Employer CSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit https://www.csl.com/accessibility-statement .